The progress of aging and life process are controlled by several factors. While one of these factors is genetic regulation [1] , oxidative stress is known to be one of the biggest external factors [2] . An animal takes in oxygen and uses it for the oxidation of glucose; the oxidation process involves the use of the mitrochondrial electron transport system [3] . At the same time, the animal gets energy to live. In the glucoseoxidation process, oxygen is converted into superoxide, hydrogen peroxide, hydroxyl radical and water [4] . These oxidative compounds are known as reactive oxygen species (ROS). ROS function as important energy-transfer systems. Furthermore, a neutro phile and a macrophage produce and release ROS during emergencies, such as the approach of a foreign enemy, bleeding and inflammation, in order to maintain and restore normal body functions. However, excessively generated ROS trigger the unregulated oxidation of the living body and often cause various diseases. In particular, oxidation of lipids, protein and DNA is known to occur frequently and to cause a significant increase in oxidative stress; for example, guanosine in DNA is easily oxidized by ROS and produces 8-deoxyguanosine [5] . Guanosine is, therefore, used as an oxidative stress marker. The accumulation of oxidative stress combined with molecular level dysfunction causes functional disorders.
Furthermore, the accumulation is thought to be associated with the age-related decline in body functions, asthenia and the risk of aging-related diseases.
ROS, which cause oxidative stress, are known to be produced not only by an endo genous system, but also via exogenous pathways such as chemical substances, foods, UV light and radiation [6] . The oxidative damage of the living body is governed by the balance between the production of ROS and the production of antioxidant-protective systems (glutathione, ascorbic acid, super oxide dismutase [SOD] , a catalase and a glutathione peroxidase) and also by the restoration system (DNA injury-restoration systems) [7] . Although the oxidative stresses that exceed endogenous restoration systems are controlled by administering ascorbic acid and various antioxidants, there are problems with the use of exogenous antioxidants; for example, problems relating to their aqueous solubility and ease of metabolism and triggering of side reactions in the entire body. Recently, our group has been focusing on a new design for a redox polymer drug [8] . We have also been focusing on anti oxidative stress nanotherapy using self-assembling polymers possessing nitroxide radicals [9, 10] . This article discusses the present status and future prospects of antioxidant treatment with new nanoparticles along with self-assembling redox polymers.
Nitroxide radicals and nanoparticles: a partnership for nanomedicine radical delivery
This article aims to provide a research update on nitroxide radical compounds for application of anti-oxidative stress therapy. Nitroxide compounds such as 2,2,6,6-tetramethylpyperidine-1-oxyl (TEMPO) can catalytically react with reactive oxygen species (ROS) and are anticipated as new anti-oxidant therapies for several diseases. However, low-molecular-weight nitroxide compounds pose several problems such as nonspecific dispersion in normal tissues, preferential renal clearance and rapid reduction of the nitroxide radical to the corresponding hydroxylamine. Nitroxide radical compounds are also known to show dose-related antihypertensive action accompanied by reflex tachycardia, increased skin temperature, and seizures. The author has recently designed novel nanoparticles, which possess nitroxide radicals in the core for novel bioimaging and nanotherapy. Nitroxide radical-containing nanoparticles (RNP) shows high safety, long blood circulation, magnetic resonance imaging and ESR imaging sensitive character and efficient therapeutic effects to several diseases such as cerebral and renal ischemia reperfusions, ulcerative colitis and Alzheimer's disease models. RNPs are, thus, promising as new nanotherapeutic materials 2 future science group Scavenging of ROS by nitroxide radicals Nitroxide radicals are unstable chemical species similar to conventional radicals. However, cyclic nitroxide compounds possessing bulky substituents are highly stable. For example, 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) (FiguRe 1 ) is known as a stable radical and can be sublimated without employing any decomposition reaction [11] . Because of its moderate stability and reactivity, TEMPO is employed in organic synthesis as a catalyst for the oxidation of primary alcohols to aldehydes [12] . Cyclic nitroxides are, thus, known as versatile catalytic reactants. Because nitroxide radicals also have the ability to react and/or interact with a free radical, they have been employed as a biophysical tool for many years [13, 14] . Owing to the ability of the radicals to degrade superoxide, inhibit Fenton reactions and undergo radical-radical recombination reactions, biological reactions involving these radicals have recently been used in novel therapies [15] . Numerous in vitro cell experiments have confirmed that nitroxide radicals effectively scavenge ROS and regulate redox conditions, which improve cell viability and biofunctions [15] .
Oxidation of TEMPO gives oxoammonium cations and TEMPO is reduced to hydroxylamine, as shown in FiguRe 2 . Both TEMPO and its oxoammonium cations can react with superoxide according to the following equations. Thus, TEMPO behaves like SOD and scavenges ROS effectively. This ability to participate in redox reactions is the reason for nitroxide compounds being used for protection against oxidative damage in several models, ranging from models of cell systems to isolated organs to whole animals.
Alternatively, nitroxide radicals have for long been utilized as tools for ESR spectroscopic studies [16] ; for example, to study spin label/oxymetry and spin trapping, because of their stability and their paramagnetic nature in vitro and in vivo. Recently, several groups have stepped up research on in vivo ESR imaging [17, 18] . Some groups have reported on pH-sensitive nitroxide radicals of the imidazolidine type or the imidazoline type for the noninvasive measurement of pH [19, 20] . Under in vivo conditions, however, such lowmolecular-weight nitroxide radicals pose several problems, such as nonspecific dispersion in normal tissues, preferential renal clearance and rapid reduction of the nitroxide radical to the corresponding hydroxylamine [21, 22] .
To solve these problems, we have designed and developed nitroxide radical-containing polymers, which have the tendency of self-assembling and forming nanoparticles (nitroxide radicalcontaining nanoparticles [RNPs] [9, 10] . Because RNPs confine nitroxide radicals to their core, their antioxidative nature weakens significantly when they have a spherical form. Since the nanoparticles also change its bio distribution, their characteristics vary significantly in comparison with low-molecular-weight antioxidants. Thus, the RNPs are thought to have the potential to be used as high-performance bio-nanoparticles, which can be used in vivo. In the following section, we discuss their toxicity and circulation in the blood stream in view of their use in vivo. 
Key Terms
Oxidative stress: Represents an imbalance between the production and suppression of reactive oxygen species. The excessively produced reactive oxygen species tends to cause toxic effects via oxidizing proteins, lipids and DNA.
Reactive oxygen species:
Chemically reactive molecules containing oxygen such as superoxide, hydrogen peroxide and hydroxyl radical. They are strongly oxidize biological systems to cause oxidative stress. [26] . Because poly(chloromethylstyrene), poly(vinyl alcohol) and TEMPO derivatives are commercially available, these polymer modification reactions are promising methods for the large-scale stable production of polymers containing nitroxide radicals. We have synthesized a nitroxide radical-containing polymer from poly(ethylene glycol)-bpoly(chloromethylstyrene) (PEG-b-PCMS) in a manner similar to that of Yoshida and colleagues. [8, 27] . 
ESR:

Nitroxide radicals in polymer
Recent developments in molecular-targeted therapy have drastically changed the concept of drug design. Drugs have evolved from traditional lowmolecular-weight synthetic compounds to highmolecular-weight compounds, such as enzymes and antibodies. Even in the case of a moleculartargeted drug, the amount of drug accumulated in the diseased area is less than a few percentage of the injected dose. Other drugs get metabolized or spread nonspecifically to normal organs, which causes severe dysfunction in the living body. In order to improve the delivery efficiency of drugs, the precise control of pharmaco kinetics is crucial. Drug delivery by nanoparticles such as polymeric micelles and liposomes can control the drug pharmacokinetics, and some of them have already been commercialized for anticancer therapy. An amphiphilic block copolymer spontaneously forms core-shell-type polymer micelles, which are extremely stable, because of the entanglement of hydrophobic chains in the core. This is the reason that polymer micelles are suitable for circulation in the blood stream in vivo, characterized by extremely dilute conditions. Low-molecular-weight surfactant micelles cannot be utilized under the same conditions below a critical micelle concentration. Polymeric micelles containing anticancer drugs were originally developed by Kataoka's and Kabanov's groups independently [28, 29] . Anticancer drugs are incorporated into micelles via physical entrapment or chemical conjugation. A number of micelles are being assessed in clinical trials [30] , and polymer micelle systems are being improved. Nishiyama et al. reported the development of a cisplatin-loaded micelle [31] , in which platinum 
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future science group is co ordinated by carboxylate groups in block copolymers consisting of PEG and polyaspartate.
Nanoparticles are known to accumulate in specific regions because of changes in the specific vascular microenvironment, for example, since neovascularity is leaky and immature lymphatic systems develop in tumor regions, highmolecular-weight compounds, such as proteins and nanoparticles, tend to accumulate in these regions (the so-called enhancement permeation and retention [EPR] effect). The EPR effect works well and highly dispersible and biocompatible nanoparticles amounting to upto 10% of the injected dose tend to accumulate in the tumor regions. More than 90% of the nanoparticles, however, spread nonspecifically in vivo after systemic administration, even in the case of nanoparticle systems. Active targeting is one of the challenges in improving nanoparticle accumulation in specific disease areas; however, to date, no remarkable effect the ligand on its biodistribution has been reported. When ligands with high specificity are incorporated on the carrier surface, the ease with which they circulate with the blood often decreases owing to the lowered colloidal stability. Even if the ligand-incorporated carrier works well in vitro, it is very difficult to effectively work under in vivo conditions. One promising way to improve the efficiency of nanotherapy is to use 'on-off regulation', whereby the nanoparticle is dormant in a non-target tissue and is activated in the target area, thus, improving treatment outcomes and decreasing side effects. Bae et al. developed a novel method for the conjugation of doxorubicin with PEG-b-poly(aspartic acid) diblock copolymers via a hydrazine linkage [32] ; the conjugation facilitates the release of doxorubicin in acidic environments, for example, in the case of acidosis and endocytosis. Thus, the conjugation facilitates the stimuli-responsive delivery As stated above, we have developed amphiphilic block copolymers possessing nitroxide radicals as a side chain of the hydrophobic segment ( FiguRe 3 ). The nanoparticles formed by these block copolymers, which are 40 nm in diameter (RNPs) [8] , show unique ESR spectra. In contrast with the free-TEMPO signal shown in FiguRe 4B , which is a clear triplet signal corresponding to an interaction between 14 N nuclei and the unpaired electron in the dilute solution, the nanoparticle signal broadens (FiguRe 4a ). The broadened ESR signal of the nanoparticle is attributable to the restricted mobility of the nitroxide radicals incorporated in the solid core of the nanoparticles. These results confirm that nitroxide radicals are present in the hydro phobic solid core of the nanoparticles. The confinement of catalytic species in the core of polymer micelles reduces their side effect and unwanted reactions under spherical form (FiguRe 5).
TEMPO derivatives are known to be biologically active substances [15, 33] . Suy et al. have reported that one of the physiological activities of nitroxide radicals in cancer cells is the promotion of apoptosis [34] . We have evaluated the toxicity of TEMPO derivatives and RNPs. FiguRe 6 shows the dose-dependent cell viabilities in colon cells treated with low-molecular-weight TEMPO, 4-amino-TEMPO, and RNPs prepared from PEG-b-PMNT (RNP N ).The colon cell viabilities are progressively reduced after 24 h with an increase in the concentrations of low-molecular-weight TEMPO and amino-TEMPO. The median inhibitory concentrations (IC 50 ) of TEMPO and 4-amino-TEMPO are 8.3 and 4.8 mM, respectively. Because amino groups generally show high toxicity, the cytotoxicity of 4-amino-TEMPO might be higher than that of TEMPO. In contrast, the RNP N induces no change in the cell viability up to a concentration of 8-mmol N/l though PEG-b-PMNT possesses a polyamine segment. The extremely low toxicity of the RNP N is probably owing to the fact that the outer PEG layer constitutes an excellent stealth shield around the amino-TEMPO moieties in the RNP core. The in vivo toxicity is evaluated using Institute of Cancer Research mice. After the administration of RNPs in the approximate range of 0-300 mg/kg, no dead mice were observed for 2 weeks. Even
Key Term
Cancer: A large group of different diseases, all involving unregulated cell growth. In cancer, cells divide and grow uncontrollably, forming malignant tumors, which invade nearby parts of the body or spread to more distant parts of the body through the lymphatic system or blood stream. The circulation of nitroxide radical compounds with the blood stream is of interest, which is monitored by ESR spectra. The ESR signals in the blood stream are hardly observed even after 2 min, when low-molecular-weight TEMPOL is administered via tail-vein injection ( FiguRe 7) . The half-life of TEMPOL in blood has been reported to be approximately 15 s [36] . On the contrary, when RNPs prepared from PEG-b-PMNT and PEG-b-PMOT (RNP O ) are administered, the ESR signal in the blood stream is observed even 2 h after the tail-vein injection of RNPs. The half-life of the RNP is 60-times longer (15 min) than that of low-molecular-weight TEMPOL. RNP O s show much longer circulation. Actually, the half-life of the RNP O is 600 min, which is 2400-times longer than that of low-molecular-weight TEMPOL. The rapid clearance of low-molecular-weight TEMPOL from the blood stream is probably a result of the preferential renal clearance and the rapid reduction of the nitroxide radical to the corresponding hydroxylamine in the blood. Compartmentalization of nitroxide radicals in the core of RNP must be the reason for improvement in the observed reduction resistance of RNPs. Actually, the ESR signals of blood are broad singlet similar to FiguRe 4 , a proof that the nitroxide radical moieties are still located in the solid core of the RNP. Thus, self-assembling structure of amphiphilic block copolymer, which confines nitroxide radicals in the solid core is one of the important factors to improve the retention of nitroxide radicals in the blood stream. 
Use of RNPs as a redox imaging tool
Poly[2-(N,N-diethylamino)ethyl methacrylate] (PEAMA) homopolymer exhibits precipitation above pH 7.5, owing to the deprotonation of the amino groups of the PEAMA [37] . Using this pH-dependent phase transition character, unique pH-sensitive nanoparticle can be prepared. Poly(ethylene glycol)-b-PEAMA block copolymer forms core-shell type polymer micelle above pH 7.5, while it disintegrates under pH 7.4 [38, 39] . Thus, polyamine with appropriate hydrophobicity can be employed for pH-sensitive material design [40, 41] . Because the PMNT segment possesses both a hydrophobic phenyl group and an amino group in each repeating unit, a similar phase-transition phenomenon is shown in response to acidic pH environments, owing to the protonation of the amino groups. In fact, the pKa value of PMNT is approximately 7.0, meaning that it is precipitate above pH 7.0, while it is soluble below pH 7.0. From the dynamic light scattering investigation, the scattering intensity drastically decreases at pH values below 6.0 in the case of RNP N s, whereas it does not decrease at all in the case of RNP O , which has no amino group in hydrophobic segment as shown in FiguRe 8 [27] . These results clearly indicate that the RNP N disintegrates at pH values below 6.0. As stated above, ESR spectra are known to give information on the local environment around the spin probe [42] . The ESR measurement of the polymers carrying nitroxide radicals thus gives us information on the dynamics of the polymer chain [25, 43] . Since the assembly of PEG-b-PMNT depends on the protonation of the amino groups,the ESR spectra should be influenced by the environmental pH. 
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future science group correlated with the disintegration of the RNP N . Crucially, the mobility of the TEMPO moieties as side chains of the PMNT segments increased with the disintegration of the RNP N core, and the distance between the nitroxide radicals increases because of the electrostatic repulsion between the protonated amino groups.
In conjunction with the phase transition, a change in the ESR signal height is observed. Indeed, a significant increase in the signal height is observed at pH values below 6.0, which confirms that the RNP N shows a phase transition at a specific pH (~pH = 6.0). This phenomenon is also observed in the L-band ESR spectra. L-band ESR imaging systems operating in low-frequency microwave bands (less than 1.2 GHz), where the dielectric losses are lower, have been developed and utilized for the in vivo imaging of animals by using a spin probe [44] . FiguRe 9B shows phantom images of RNPs in a glass vial at pH 5.6 and 7.4. An appropriate threshold (cutoff 40%) is used for deionizing water solution. The phantom images clearly show a remarkable on-off regulation in the capillary glass tube. Since RNPs can be delivered to tumor and inflammation sites effectively, the RNP N might emit strong ESR signals in vivo by disintegration in low pH conditions. This is our strategy for imaging under low pH conditions by using pH-sensitive RNP N s. From these results, the RNP N might be used as a nanoprobe for in vivo ESR imaging under low pH conditions.
Effectiveness of RNPs for ischemia-reperfusion injuries
Ischemic cardiovascular disease is the second leading cause of death in the world owing to the disruption of blood supply to the vital organs [45] . It is known that arterial recanalization achieved by thrombolysis and intravascular intervention are the main treatment strategies to restore blood supply in ischemic stroke and heart attack patients [46] . However, reperfusion can lead to ischemia-reperfusion (IR) injury, which is caused by ROS, and the injury can increase the extent of the damaged area [47] [48] [49] [50] [51] [52] . Protection of organs that can be affected by ROS has been shown to prevent the increase in the extent of the damaged area associated with the arterial occlusion. The nitroxide radical can catalytically react with ROS as stated in the section titled 'Scavenging of ROS by nitroxide radicals', and it could improve the functional outcome of patients with ischemic brain and heart diseases by scavenging free radicals at the IR injury site [53] [54] [55] [56] [57] . However, these low-molecular-weight nitroxide radical compounds have not been used clinically because they are inactivated by strong reduction by antioxidant systems, such as catalase and glutathione peroxidase in vivo [54, 56, 58] . Nanoparticle therapy based on RNP N s is effective for the accumulation of the nanoparticles in the IR area, and it helps avoid problems related to the bioavailability and biocompatibility of the nanoparticles.
In order to confirm the effectiveness of RNPs for treating IR injury, the mouse renal IR model is employed. The ex vivo ESR assessment is utilized after intravenous administration of RNPs to mice subjected to IR injury. FiguRe 10 shows the ESR spectra of the blood and kidney 
Key Term
Ischemia-reperfusion injury: Tissue damage caused when blood supply returns to the tissue after a period of ischemia or lack of oxygen. Ischemia-reperfusion injury is caused by reactive oxygen species and can enhance the damage sustained in the ischemic organ. The therapeutic effect of RNPs on acute kidney injury (AKI) is monitored by considering parameters that reflect renal functioning, such as the blood urea nitrogen (BUN) and creatinine (Cr) levels. 24 h after the reperfusion, the RNP N -treated mice show extremely low BUN and Cr levels as compared with both non-treatedmice and low-molecular-weight TEMPO compounds ( FiguRe 11) . It is interesting to note that the therapeutic effect of RNP N s is greater than that of RNP O s, though the circulation of RNP O s is much longer than that of RNP N . The fact strongly suggests that the disintegration of the RNP N improves its therapeutic efficiency. As shown in FiguRe 11c , hematoxylin and eosin (HE) staining reveals that tubular cell swelling, interstitial edema, and tubular dilatation aremuch more severe in the vehicle-treated IR mice than in the sham-operated mice. Compared to other treatments, the treatment with RNP N s results in significantly less damage, consisting with low blood concentration of BUN and Cr.
The antioxidative effect of RNPs is confirmed on the basis of the detection of ROS and lipid peroxidation. As shown in FiguRe 12a & B 
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future science group production of ROS in the kidney is significantly inhibited by the treatment with RNP N s, in comparison to other treatments. Compared with the other treatments, the treatment with RNP N s results in a significant reduction of the thio barbituric acid reactive substance (TBARS) level, which serves as an index of lipid peroxidation in the kidney, and the generation of inflammatory cytokine in plasma, as can be seen in FiguRe 12c & D, respectively. In particular, the TBARS level of the RNP N -treated group is statistically lower than that of the other groups, as shown in FiguRe 12c . On the basis of these evidence, the prolonged retention of nitroxide radicals in the kidney might be an important factor in the protection of renal function after IR because excess ROS gradually continue to be generated after reperfusion [59] . In addition, the site-specific disintegration of RNP N s in the targeted organs would lead to improved therapeutic effect on Ischemia reperfution -acute kidney injury, as compared with the case of RNP O s, regardless of longest distribution time of RNP O s in ischemic renal injury.
Though a mechanism is not clear, nitroxide radical compounds are known to show dose-related antihypertensive action accompanied by reflex tachycardia, increased skin temperature and seizures [60] . Hypotensive action would thus, lead to serious complications during treatment and surgery. For example, 4-amino-TEMPO and TEMPOL drastically decrease the mean arterial blood pressure as shown in FiguRe 13 , which was measured 15 min after the intravenous administration of drugs. In contrast, both RNPs inhibit any decrease in the arterial blood pressure. There are no significant differences between the non-treated, RNP N and RNP O groups. Although the reason for this observation is unknown, it is thought that the reduction in the arterial blood pressure after the administration of low-molecular-weight TEMPO derivatives is a consequence of an increase in the endogenous nitric oxide (NO), resulting in vasodilatation 
future science group in vivo [61, 62] . These results demonstrate that RNPs protect against blood-pressure fluctuations, because of the encapsulation of nitroxide radical moieties in the hydrophobic core of the nanoparticles in the blood stream.
A similar effect has been confirmed in the case of cerebral ischemia reperfusion injury [63] . Intravenous administration of RNP N s to transient middle-cerebral-artery-occlusion-model rats confirms that the infarct volume in the RNP group is significantly smaller than that in saline, micelle, and low-molecular-weight TEMPOL groups (FiguRe 14a). Comparison of neurological symptom scores shows that the RNP group has a significantly lower score than the saline, micelle, and TEMPOL groups (P<0.05, P<0.01 and P<0.05, respectively) as observed in FiguRe 14B . These data revealed that the RNP N s could limit the extent of cerebral infarction caused by IR injury and improve neurological deficits. 
Future perspective
Excessively generated ROS trigger unregulated oxidation of the living body and often cause various diseases, as stated above. The nitroxide radical works effectively as a catalytic redox reactant. Low-molecular-weight compounds, however, lead to several problems such as therapid metabolism, excretion and reduction of the compounds in living systems and triggering of side reactions. The confinement of nitroxide radicals in the core of the nanoparticle reduces its toxicity and improve the ease with which it can circulate with the blood in the blood stream. The disintegration of RNPs in acidic ischemia regions renders the RNPs an effective anti oxidant spatio-temporally; the RNPs are inert when nonspecifically distributed to other areas. This is a promising strategy for the realization of a novel therapeutic system.
Because nanoparticles with high dispersion tend to permeate leaky neovascular regions, such as tumor and inflammation sites (the socalled EPR effect), they are thought to accumulate in these areas (passive targeting). Because the living body obtains energy via the mitochondrial electron transport system, an antioxidative drug must not suppress this regular system. Because the nanoparticle distribution in vivo varies with the size of the nanoparticles, it is believed that they do not suppress the normal oxidation reaction in mitochondria. This may be one of the reasons for the extremely low toxicity of RNPs in vivo. Although it is clear that one of the reasons is the compartmentalization of the redox center (nitroxide radicals) in the core of the nano particle, the controlled biodistribution of the RNPs might play an important role.
RNPs effectively scavenge unwanted ROS in the case of IR injuries without any significant side effect. They suppress the generation 
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future science group of inflammatory cytokines and quench ROS production. Similar observations have been made in the case of other disease models. RNPs suppress excessive inflammation after cerebral hemorrhage induced by focusing ultrasound beam radiation coupled with fluorocarbon microbubbles [64] . Considering both scavenging of ROS in penumbra areas and suppression of intracerebral hemorrhage, RNP nanotherapy is an ideal therapy for cerebral infarction. This redox nanotherapeutic strategy can be extended further to Alzheimer's disease models in vitro [65] . Recently, the administration of RNPs to tumor-bearing mice was found to increase the effectiveness of the anticancer drug Adriamycin in subcutaneously inoculated cancer-bearing mice [66] . Since RNPs suppress the side reactions triggered by Adriamycin, especially in the heart and liver, they may be a suitable adjuvant in cancer therapy [67] . RNPs also improve the gene transfection efficiency associated with a polyplex system [68] .
One of the potential research areas in redox nanotherapy is to find new routes for nanoparticle administration. If nanoparticles can be administered orally, they can be used for treating chronic diseases. Orally administered RNP O s are captured by the colon mucous membrane without requiring their entry into the blood stream; this fact makes RNP O s a promising candidate for the treatment of bowel inflammatory disease. In fact, RNP O s have been found to effectively suppress inflammation in a DSS-induced ulcerative colitis mouse model [69] . Since RNP O s do not enter the blood stream, there are no side reactions. Administration through nasal, pulmonary and other routes can help in the development of new redox nanotherapies, because oxidative stress causes many diseases.
On the basis of the obtained data, selfassembling redox nanoparticle, RNP, is confirmed to show high efficiencies to versatile disease, which is mainly accomplished by the delivery and on-off regulation by pH. Recently, it comes to be known that gaseous molecules such as carbon monoxide, nitrogen monoxide, hydrogen sulfide and hydrogen play important roles in vivo. These gaseous molecules were involved to versatile redox reactions in vivo to maintain or destruct homeostasis of living body. However, it is important to precisely control delivery of these gaseous molecules to specific region in order to utilize them for therapy because it has strong bioactivity. Several works on the control of confinement and controlled delivery of these gaseous molecules are reported. Hasegawa et al. reported carbon monoxide-releasing polymer micelle for immunotherapy [70] . We prepared a nanoparticle, which releases nitrogen oxide by photo irradiation [71] . Controlled delivery, generation and scavenging of these gaseous molecules including ROS are promising technology for next generation for radical delivery of nanotherapeutic systems.
Executive summary
We have designed and developed nitroxide radical-containing polymers, which have the tendency of self-assembling and forming nanoparticles (nitroxide radical-containing nanoparticles [RNPs]).
Scavenging of reactive oxygen species (ROS) by nitroxide radicals -Nitroxide radical reacts with ROS effectively, which can be regarded as a new drug for redox antioxidant. Nitroxide compounds possessing controlled reactivity can be synthesized chemically.
Manufacture of radical-containing polymers and particles -Because many types of nitroxide compounds are very stable, it is easy to install versatile types of polymers.
Nitroxide radicals in polymer -Because RNPs confine nitroxide radicals to their core, their antioxidative nature weakens significantly when they have a spherical form, the character of which reduces their toxicity and suppresses the side effects.
Use of RNPs as a redox imaging tool -pH-responsive RNP (RNP N ) disintegrates at pH below 7.0 to expose nitroxide radicals, which are monitored by both X-and L-band ESR spectra. Thus, it is anticipated as pH-dependent new ESR imaging tools.
Effectiveness of RNPs for ischemia-reperfusion injuries -Since the nanoparticles also change its biodistribution, their characteristics vary significantly incomparisonto low-molecular-weight antioxidants. Long blood-circulation time improves their therapeutic efficiency. RNP N effectively scavenge ROS in ischemiareperfusion sites and can be utilized as a new redox nanomedicine. RNPs are also effective several disease models in animals such as, intracerebral hemorrhage, ulcerative colitis and cancer, thus promising as novel type redox nanomedicine.
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First evidence that RNPs effectively disintegrates injured kidney area in vivo. 28 
